Provided by Tiger Trade Technology Pte. Ltd.

Ovid Therapeutics Inc.

1.47
+0.13009.70%
Post-market: 1.470.00000.00%16:04 EST
Volume:1.93M
Turnover:2.76M
Market Cap:104.68M
PE:-2.91
High:1.48
Open:1.30
Low:1.30
Close:1.34
52wk High:2.01
52wk Low:0.2425
Shares:71.21M
Float Shares:59.52M
Volume Ratio:1.51
T/O Rate:3.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5047
EPS(LYR):-0.3663
ROE:-60.06%
ROA:-29.33%
PB:2.34
PE(LYR):-4.01

Loading ...

Sep 23, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Sep 19, 2019

Major Issues Report

Current report, items 3.02, 5.03, 5.07, and 9.01
Sep 12, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Sep 09, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 07, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Aug 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 02, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jun 27, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Jun 27, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jun 18, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jun 17, 2019

Major Issues Report

[Amend] Current report, items 1.01 and 9.01
Jun 10, 2019

Major Issues Report

Current report, item 5.07
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 15, 2019

Major Issues Report

Current report, items 1.01 and 9.01
May 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01